Search Results - "Toma, Ilaria"

Adjuvant chemotherapy after neoadjuvant chemo-radiotherapy and surgery in locally advanced rectal cancer. A systematic review of literature with a meta-analysis of randomized clinical trials by Tamburini, Emiliano, Tassinari, Davide, Ramundo, Matteo, De Stefano, Alfonso, Viola, Massimo Giuseppe, Romano, Carmela, Elia, Maria Teresa, Zanaletti, Nicoletta, Rudnas, Britt, Casadei-Gardini, Andrea, Delrio, Paolo, Toma, Ilaria, Granata, Vincenza, Petrucelli, Luciana, Avallone, Antonio

“…Although no definitive data exist in literature, adjuvant chemotherapy is usually recommended in patients with radically resected stage III rectal cancer…”
Get full text

Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy by Schepisi, Giuseppe, Casadei, Chiara, Toma, Ilaria, Poti, Giulia, Iaia, Maria Laura, Farolfi, Alberto, Conteduca, Vincenza, Lolli, Cristian, Ravaglia, Giorgia, Brighi, Nicole, Altavilla, Amelia, Martinelli, Giovanni, De Giorgi, Ugo

“…Gynecological tumors are malignancies with both high morbidity and mortality. To date, only a few chemotherapeutic agents have shown efficacy against these…”
Get full text

FOLFOXIRI plus bevacizumab and atezolizumab as upfront treatment of unresectable metastatic colorectal cancer (mCRC): Updated and overall survival results of the phase II randomized AtezoTRIBE study by Antoniotti, Carlotta, Rossini, Daniele, Pietrantonio, Filippo, Salvatore, Lisa, Marmorino, Federica, Ambrosini, Margherita, Lonardi, Sara, Bensi, Maria, Moretto, Roberto, Tamberi, Stefano, Toma, Ilaria, Passardi, Alessandro, De Grandis, Maria Caterina, Conca, Veronica, Palermo, Federica, Cappetta, Alessandro, Catteau, Aurelie, Boni, Luca, Galon, Jérôme, Cremolini, Chiara

“…3500 Background: AtezoTRIBE (NCT03721653) is a phase II randomized trial in which unresectable mCRC pts were randomized 1:2 to 1 st -line FOLFOXIRI/bev [arm A]…”
Get full text

Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide by Conteduca, Vincenza, Casadei, Chiara, Scarpi, Emanuela, Brighi, Nicole, Schepisi, Giuseppe, Lolli, Cristian, Gurioli, Giorgia, Toma, Ilaria, Poti, Giulia, Farolfi, Alberto, De Giorgi, Ugo

“…Background: Baseline high circulating tumor DNA (ctDNA) fraction in plasma and androgen receptor (AR) copy number (CN) gain identify mCRPC patients with worse…”
Get full text

Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm? by Tommasi, Chiara, Balsano, Rita, Corianò, Matilde, Pellegrino, Benedetta, Saba, Giorgio, Bardanzellu, Fabio, Denaro, Nerina, Ramundo, Matteo, Toma, Ilaria, Fusaro, Alessandro, Martella, Serafina, Aiello, Marco Maria, Scartozzi, Mario, Musolino, Antonino, Solinas, Cinzia

“…Breast cancer is still a lethal disease and the leading cause of death in women, undermining patients' survival and quality of life. Modern techniques of…”
Get full text

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study by Rimini, Margherita, Masi, Gianluca, Lonardi, Sara, Nichetti, Federico, Pressiani, Tiziana, Lavacchi, Daniele, Jessica, Lucchetti, Giordano, Guido, Scartozzi, Mario, Tamburini, Emiliano, Pastorino, Alessandro, Rapposelli, Ilario Giovanni, Daniele, Bruno, Martinelli, Erika, Garajova, Ingrid, Aprile, Giuseppe, Schirripa, Marta, Formica, Vincenzo, Salani, Francesca, Winchler, Costanza, Bergamo, Francesca, Balsano, Rita, Gusmaroli, Eleonora, Lorenzo, Angotti, Landriscina, Matteo, Pretta, Andrea, Toma, Ilaria, Pirrone, Chiara, Diana, Anna, Leone, Francesco, Brunetti, Oronzo, Brandi, Giovanni, Garattini, Silvio Ken, Satolli, Maria Antonietta, Rossari, Federico, Fornaro, Lorenzo, Niger, Monica, Zanuso, Valentina, De Rosa, Antonio, Ratti, Francesca, Aldrighetti, Luca, De Braud, Filippo, Foti, Silvia, Rizzato, Mario Domenico, Vivaldi, Caterina, Stefano, Cascinu, Rimassa, Lorenza, Antonuzzo, Lorenzo, Casadei-Gardini, Andrea

“…Background The TOPAZ-1 phase III trial reported a survival benefit with the anti-programmed cell death ligand 1 (anti-PD-L1) durvalumab in combination with…”
Get full text

PNEUMATOSIS CYSTOIDES INTESTINALIS DURING THE TREATMENT WITH PACLITAXEL FOR METASTATIC OVARIAN CANCER by Luca Perrucci

“…Gas within the bowel wall can be an incidental finding in Computed Tomography (CT) exams, with increased frequency in oncological patients. Pneumatosis…”
Get full text

Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy by Conteduca, Vincenza, Caffo, Orazio, Scarpi, Emanuela, Sepe, Pierangela, Galli, Luca, Fratino, Lucia, Maines, Francesca, Chiuri, Vincenzo Emanuele, Santoni, Matteo, Zanardi, Elisa, Massari, Francesco, Toma, Ilaria, Lolli, Cristian, Schepisi, Giuseppe, Sbrana, Andrea, Kinspergher, Stefania, Cursano, Maria Concetta, Casadei, Chiara, Modonesi, Caterina, Santini, Daniele, Procopio, Giuseppe, De Giorgi, Ugo

“…Androgen deprivation therapy (ADT) is a cornerstone of treatment for prostate cancer and, in recent years, androgen receptor (AR)-targeted therapies…”
Get full text